(19)
(11) EP 2 435 825 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.09.2015 Bulletin 2015/36

(45) Mention of the grant of the patent:
15.07.2015 Bulletin 2015/29

(21) Application number: 10779928.0

(22) Date of filing: 27.05.2010
(51) International Patent Classification (IPC): 
G06F 19/12(2011.01)
A61B 5/00(2006.01)
 G06F 19/24(2011.01)
(86) International application number:
PCT/AU2010/000649
(87) International publication number:
WO 2010/135781 (02.12.2010 Gazette 2010/48)

(54)

METHODS OF TREATING DISEASES

KRANKHEITSBEHANDLUNGSVERFAHREN

PROCÉDÉS DE TRAITEMENT DE MALADIES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 27.05.2009 US 181508 P

(43) Date of publication of application:
04.04.2012 Bulletin 2012/14

(60) Divisional application:
15170346.9

(73) Proprietor: Biotempus Limited
Fitzroy, VIC 3065 (AU)

(72) Inventors:
  • ASHDOWN, Martin, Leonard
    Thornbury Victoria 3071 (AU)
  • ROBINSON, Andrew
    Seaford Victoria 3198 (AU)

(74) Representative: Dempster, Robert Charles et al
Maschio & Soames IP Limited 20 Carlton Crescent
Southampton SO15 2ET
Southampton SO15 2ET (GB)


(56) References cited: : 
WO-A1-2005/040816
 WO-A1-2006/026821
   
  • COVENTRY, B. J. ET AL.: 'CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?' JOURNAL OF TRANSLATIONAL MEDICINE vol. 7, 2009, page 102, XP021063594
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).